Navigation Links
ALS Therapy Development Institute Awarded $1M Grant
Date:10/28/2008

RGK Foundation grant will support the creation of potential gene therapies to treat ALS

CAMBRIDGE, Mass., Oct. 28 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute announced today that it has been awarded a $1 million grant from the RGK Foundation of Austin, Texas. The grant, to be awarded over 18 months, will support the institute's on-going efforts to utilize the latest gene therapy technology to develop an effective therapeutic to slow or stop the progression of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease.

"We are grateful and honored to have the trust and support of the RGK Foundation. It is imperative that the latest gene therapy technologies and therapeutic validation strategies be brought to bear on this relentless disease. This investment by the RGK Foundation is just the latest in their long commitment to supporting innovative research at ALS TDI and elsewhere," said Dr. Steve Perrin, Chief Scientific Officer at ALS TDI.

The grant will support research designed to identify and develop gene specific viral vectors at ALS TDI, including in vitro validation and the development of sufficient vector stocks to conduct full in vivo validation projects. Support from individuals and organizations, such as the RGK Foundation, enables the institute to advance increasing numbers of high-priority therapeutic targets through its rigorous validation process. Currently, the research team at ALS TDI has more than 40 different research projects going on in its 16,000 square foot research center in Cambridge, Massachusetts.

The Kozmetsky family and the RGK Foundation have been supporting the important work of ALS TDI over several years. In 2003, Ronya Kozmetsky co-founder of the RGK Foundation, provided the institute with $1 million to build the Kozmetsky Drug Testing and Knowledge Nexus Initiative. This investment allowed ALS TDI to further its drug discovery and testing capabilities and upgrade
'/>"/>

SOURCE ALS Therapy Development Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Green Valley Spa Now Offers hCG Weight Loss Therapy
2. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
3. Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks
4. Light-Activated Therapy Seems to Rejuvenate Aging Skin
5. New Method of Therapy Takes Patients Out of the Clinic and Into the Park
6. Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers
7. Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems
8. NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
9. Schwabe, World Leader in Herbal Manufacturing Will Acquire Enzymatic Therapy Through Natures Way Holding, Inc.
10. HelpPRO and Give an Hour Join to Help Military Families Get Free Therapy Services
11. FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... Wind Turbines are popping ...g from growing mushrooms, making wine to keeping p...B) December 5, 2009 -- Who would have thought that...rom Wind Turbines? Wind Inc. of Fort Worth, Texas ... end users, not wind farms. "Using a technology d...
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 Allied World ...ay announced that Scott Carmilani,President and Ch... Vice,President and Chief Corporate Strategy Offic....S. Financial Services Conference being held at th... on Tuesday, December 8, 2009. ,, About Allied...
(Date:12/4/2009)... , ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief...elected as a finalist for the "Chief Innovation Of...ness with the power of cloud computing. Appy Award...e usage of Salesforce CRM or the Force.com platfor...eir sales, marketing, partner, service, support or...
(Date:12/4/2009)...Working with mice, scientists at Johns Hopkins pub...shown that a protein made by a gene called "Twist"...y distinguish stem cells that drive aggressive, me...lls. , Building on recent work suggesting that it...east tumors that drives breast cancer, scientists ...
(Date:12/4/2009)...comes same whether procedure done immediately or 3... 4 (HealthDay News) -- Timing of surgical repair o...s may not affect patient outcome, a new study has ...om traumatic knee dislocations that can occur in h...ptimal time to perform surgery to repair these inj...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
... AFL ) announced today that it will make a present...y-Fourth Annual Strategic Decisions Conference,200...loninger III will,represent Aflac Incorporated, an...ny,s outlook for 2008 and its strategy for,growth ...
...stopher Georgacas and Mark Mi...At its Board Meeting earlier today,the Board of Di...llion in,new grants to expand QUITPLAN(R) Services...ard also welcomed three new,Board Members, the Hon...
... allergy symptoms, PROVIDENCE, R.I., May 21 Apri......sneezes?, For those allergy sufferers out ther...the end of cold weather and snow is certainly welc... Month,and CleanBrands, creators of The World,s Cl...
...erations and new agr...TC,Bulletin Board: ISCR), a leading distributor of...ll, life-saving prescription drugs and a developer...t,highlights include:, -- Revenue grew by 258% i...
...reast Cancer Research Fund, WEST CHESTER, Pa., Ma...y when leading multimedia retailer QVC(R) once aga...7 at 1 AM (ET) and 6 PM,(ET). These two one-hour p...newscom.com/cgi-bin/prnh/20070923/NESU001LOGO ), ...
... played,host to nearly 300 guests at its PowerPlex...ent speaker who provided a poignant report on the ...newscom.com/cgi-bin/prnh/20070627/CLW071LOGO ), ...His remarks included the findings of a survey cond...
Other Medicine News:Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 3Health News:Spring Allergies Got You Down? Try Some of These Drug-Free Options 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:A Touch of Pink Never Looked So Good 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 3
(Date:12/3/2009)...WARRENDALE, Pa., Dec. 3 Radiology imaging leader ...ntegration capabilities at the November 2009 Radio...nnect.PACS(TM) product, enabling the first radiol...atest release in the company,s newly branded Cert...p://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, D...iR-122, a microRNA Important for,Hepatitis C Viral...itis C,Virus in the Bloodstream in Chimpanzees Chr... - SPC3649 Demonstrates Efficacy With No Evidence ...in the Treated Animals - Signaling a Potential,Ben...
(Date:12/3/2009)....C., Dec. 3 In response to the increasingly criti... the evolving healthcare delivery system, Duke Med...matics (DCHI) to provide a campus focus for health...rdisciplinary approach to education that will prod...lthcare administrators with an expertise in the us...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 1With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 2With Hormone Therapy Tender Breasts May Signal Cancer Risk 59307 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 1Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 2Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 3Slavica Bio Chem 28HTDS 29 Subsidiary Medical Team Message 59304 4
...15 Pre-mixed insulin,analogues, a modified form o...ffective than long-acting analogues for controllin...with type 2 diabetes, according to a report,funded..., part of the U.S.,Department of Health and Human ...however, appears to be equally,effective as pre-mi...
.... 15 , -- Results inconclusive, as primary outcom...ther donepezil or AZD3480; results impacted by ...own on secondary outcome measures ADCS-CGIC and MM...mparable to placebo, with fewer GI-related AEs...alysis of full dataset and planned discussions...
Other Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
Teardrop punch, Left
Meniscus Screw
Biosteon™ (HA/PLLA) Wedge Interference Screws
Graft Workstation
Medicine Products: